<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC2991431/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genome Wide Association Study to Identify Single Nucleotide Polymorphisms (SNPs) Associated with the Development of Erectile Dysfunction in African-American Men Following Radiotherapy for Prostate Cancer</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991431/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="International journal of radiation oncology, biology, physics"><meta name="citation_title" content="Genome Wide Association Study to Identify Single Nucleotide Polymorphisms (SNPs) Associated with the Development of Erectile Dysfunction in African-American Men Following Radiotherapy for Prostate Cancer"><meta name="citation_authors" content="Sarah L. Kerns, Harry Ostrer, Richard Stock, William Li, Julian Moore, Alexander Pearlman, Christopher Campbell, Yongzhao Shao, Nelson Stone, Lynda Kusnetz, Barry S. Rosenstein"><meta name="citation_date" content="1 December 2010"><meta name="citation_issue" content="5"><meta name="citation_volume" content="78"><meta name="citation_firstpage" content="1292"><meta name="citation_doi" content="10.1016/j.ijrobp.2010.07.036"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2991431/?report=abstract"><meta name="citation_pmid" content="20932654"><meta name="DC.Title" content="Genome Wide Association Study to Identify Single Nucleotide Polymorphisms (SNPs) Associated with the Development of Erectile Dysfunction in African-American Men Following Radiotherapy for Prostate Cancer"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Sarah L. Kerns"><meta name="DC.Contributor" content="Harry Ostrer"><meta name="DC.Contributor" content="Richard Stock"><meta name="DC.Contributor" content="William Li"><meta name="DC.Contributor" content="Julian Moore"><meta name="DC.Contributor" content="Alexander Pearlman"><meta name="DC.Contributor" content="Christopher Campbell"><meta name="DC.Contributor" content="Yongzhao Shao"><meta name="DC.Contributor" content="Nelson Stone"><meta name="DC.Contributor" content="Lynda Kusnetz"><meta name="DC.Contributor" content="Barry S. Rosenstein"><meta name="DC.Date" content="2010 Dec 1"><meta name="DC.Identifier" content="10.1016/j.ijrobp.2010.07.036"><meta name="DC.Language" content="en"><meta property="og:title" content="Genome Wide Association Study to Identify Single Nucleotide Polymorphisms (SNPs) Associated with the Development of Erectile Dysfunction in African-American Men Following Radiotherapy for Prostate Cancer"><meta property="og:type" content="article"><meta property="og:description" content="To identify single nucleotide polymorphisms (SNPs) associated with erectile dysfunction (ED) among African American prostate cancer patients treated with external beam radiation therapy (EBRT).A cohort of African American prostate cancer patients treated ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991431/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2991431/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2991431/pdf/nihms225345.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8B2595DD5105E1000000000846056D.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2991431%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC2991431</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Int J Radiat Oncol Biol Phys</a></span>. Author manuscript; available in PMC 2011 Dec 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=20932654" target="pmc_ext" ref="reftype=publisher&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Int J Radiat Oncol Biol Phys. 2010 Dec 1; 78(5): 1292–1300. </span></a></div> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1016%2Fj.ijrobp.2010.07.036" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1016/j.ijrobp.2010.07.036</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2991431</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS225345</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/20932654">20932654</a></div></div></div></div><h1 class="content-title">Genome Wide Association Study to Identify Single Nucleotide Polymorphisms (SNPs) Associated with the Development of Erectile Dysfunction in African-American Men Following Radiotherapy for Prostate Cancer</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Kerns%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654" class="affpopup" co-rid="_co_idm140624695960752" co-class="co-affbox">Sarah L. Kerns</a>, Ph.D., M.P.H.,<sup>1</sup> <a href="/pubmed/?term=Ostrer%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654" class="affpopup" co-rid="_co_idm140624768768784" co-class="co-affbox">Harry Ostrer</a>, M.D.,<sup>1</sup> <a href="/pubmed/?term=Stock%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654" class="affpopup" co-rid="_co_idm140624700391296" co-class="co-affbox">Richard Stock</a>, M.D.,<sup>2</sup> <a href="/pubmed/?term=Li%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654" class="affpopup" co-rid="_co_idm140624695058272" co-class="co-affbox">William Li</a>, M.D.,<sup>3</sup> <a href="/pubmed/?term=Moore%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654" class="affpopup" co-rid="_co_idm140624691698272" co-class="co-affbox">Julian Moore</a>, D.O.,<sup>2</sup> <a href="/pubmed/?term=Pearlman%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654" class="affpopup" co-rid="_co_idm140624688784064" co-class="co-affbox">Alexander Pearlman</a>, Ph.D.,<sup>1</sup> <a href="/pubmed/?term=Campbell%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654" class="affpopup" co-rid="_co_idm140624734795760" co-class="co-affbox">Christopher Campbell</a>, B.S.,<sup>1</sup> <a href="/pubmed/?term=Shao%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654" class="affpopup" co-rid="_co_idm140624696716544" co-class="co-affbox">Yongzhao Shao</a>, Ph.D.,<sup>4</sup> <a href="/pubmed/?term=Stone%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654" class="affpopup" co-rid="_co_idm140624687922992" co-class="co-affbox">Nelson Stone</a>, M.D.,<sup>2,</sup><sup>5</sup> <a href="/pubmed/?term=Kusnetz%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654" class="affpopup" co-rid="_co_idm140624697367776" co-class="co-affbox">Lynda Kusnetz</a>, B.A.,<sup>2</sup> and  <a href="/pubmed/?term=Rosenstein%20BS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654" class="affpopup" co-rid="_co_idm140624698719040" co-class="co-affbox">Barry S. Rosenstein</a>, Ph.D.<sup>2,</sup><sup>6</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140624695960752"><h3 class="no_margin">Sarah L. Kerns</h3><p><sup>1</sup>Department of Pediatrics, New York University School of Medicine, Tisch Hospital Room 508, 550 First Avenue, New York, NY 10016</p><div>Find articles by <a href="/pubmed/?term=Kerns%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654">Sarah L. Kerns</a></div></div><div id="_co_idm140624768768784"><h3 class="no_margin">Harry Ostrer</h3><p><sup>1</sup>Department of Pediatrics, New York University School of Medicine, Tisch Hospital Room 508, 550 First Avenue, New York, NY 10016</p><div>Find articles by <a href="/pubmed/?term=Ostrer%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654">Harry Ostrer</a></div></div><div id="_co_idm140624700391296"><h3 class="no_margin">Richard Stock</h3><p><sup>2</sup>Department of Radiation Oncology, Box 1236, Mount Sinai School of Medicine, New York, NY 10029</p><div>Find articles by <a href="/pubmed/?term=Stock%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654">Richard Stock</a></div></div><div id="_co_idm140624695058272"><h3 class="no_margin">William Li</h3><p><sup>3</sup>Queens/Elmhurst Hospital Center, Department of Radiation Oncology, 82-68 164<sup>th</sup> Street, Jamaica, NY 11432</p><div>Find articles by <a href="/pubmed/?term=Li%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654">William Li</a></div></div><div id="_co_idm140624691698272"><h3 class="no_margin">Julian Moore</h3><p><sup>2</sup>Department of Radiation Oncology, Box 1236, Mount Sinai School of Medicine, New York, NY 10029</p><div>Find articles by <a href="/pubmed/?term=Moore%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654">Julian Moore</a></div></div><div id="_co_idm140624688784064"><h3 class="no_margin">Alexander Pearlman</h3><p><sup>1</sup>Department of Pediatrics, New York University School of Medicine, Tisch Hospital Room 508, 550 First Avenue, New York, NY 10016</p><div>Find articles by <a href="/pubmed/?term=Pearlman%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654">Alexander Pearlman</a></div></div><div id="_co_idm140624734795760"><h3 class="no_margin">Christopher Campbell</h3><p><sup>1</sup>Department of Pediatrics, New York University School of Medicine, Tisch Hospital Room 508, 550 First Avenue, New York, NY 10016</p><div>Find articles by <a href="/pubmed/?term=Campbell%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654">Christopher Campbell</a></div></div><div id="_co_idm140624696716544"><h3 class="no_margin">Yongzhao Shao</h3><p><sup>4</sup>Division of Biostatistics, New York University School of Medicine, Room 538, 650 First Avenue, New York, NY 10016</p><div>Find articles by <a href="/pubmed/?term=Shao%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654">Yongzhao Shao</a></div></div><div id="_co_idm140624687922992"><h3 class="no_margin">Nelson Stone</h3><p><sup>2</sup>Department of Radiation Oncology, Box 1236, Mount Sinai School of Medicine, New York, NY 10029</p><p><sup>5</sup>Department of Urology, Mount Sinai School of Medicine, New York, NY 10029</p><div>Find articles by <a href="/pubmed/?term=Stone%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654">Nelson Stone</a></div></div><div id="_co_idm140624697367776"><h3 class="no_margin">Lynda Kusnetz</h3><p><sup>2</sup>Department of Radiation Oncology, Box 1236, Mount Sinai School of Medicine, New York, NY 10029</p><div>Find articles by <a href="/pubmed/?term=Kusnetz%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654">Lynda Kusnetz</a></div></div><div id="_co_idm140624698719040"><h3 class="no_margin">Barry S. Rosenstein</h3><p><sup>2</sup>Department of Radiation Oncology, Box 1236, Mount Sinai School of Medicine, New York, NY 10029</p><p><sup>6</sup>Department of Radiation Oncology, New York University School of Medicine, New York, NY 10016</p><div>Find articles by <a href="/pubmed/?term=Rosenstein%20BS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20932654">Barry S. Rosenstein</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140624696690208_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140624696690208_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140624696690208_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>Department of Pediatrics, New York University School of Medicine, Tisch Hospital Room 508, 550 First Avenue, New York, NY 10016</div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>Department of Radiation Oncology, Box 1236, Mount Sinai School of Medicine, New York, NY 10029</div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>Queens/Elmhurst Hospital Center, Department of Radiation Oncology, 82-68 164<sup>th</sup> Street, Jamaica, NY 11432</div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>Division of Biostatistics, New York University School of Medicine, Room 538, 650 First Avenue, New York, NY 10016</div><div class="fm-affl" id="A5" lang="en"><sup>5</sup>Department of Urology, Mount Sinai School of Medicine, New York, NY 10029</div><div class="fm-affl" id="A6" lang="en"><sup>6</sup>Department of Radiation Oncology, New York University School of Medicine, New York, NY 10016</div><div id="cor1">Corresponding author: Barry Rosenstein, Ph.D., Department of Radiation Oncology, Atran Laboratory Building, 2nd Floor Room 206, 1428 Madison Avenue, New York, NY 10029. Tel: 212-241-9408, Fax: 212-996-8927, <a href="mailto:dev@null" data-email="ude.mssm@nietsnesor.yrrab" class="oemail">ude.mssm@nietsnesor.yrrab</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140624696690208_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div><div><a href="#FN1">Publisher's Disclaimer</a></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=20932654" target="pmc_ext" ref="reftype=publisher&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Int J Radiat Oncol Biol Phys</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC2991431/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="idm140624697105344" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140624697105344title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Purpose</h3><p id="P1" class="p p-first-last">To identify single nucleotide polymorphisms (SNPs) associated with erectile dysfunction (ED) among African American prostate cancer patients treated with external beam radiation therapy (EBRT).</p></div><div id="S2" class="sec"><h3 id="S2title">Methods and Materials</h3><p id="P2" class="p p-first-last">A cohort of African American prostate cancer patients treated with EBRT was followed for development of ED using the five-item Sexual Health Inventory for Men (SHIM) questionnaire. Final analysis included 27 cases (post-treatment SHIM score ≤ 7) and 52 controls (post-treatment SHIM score ≥ 16). A genome-wide association study was performed using ∼909,000 SNPs genotyped on Affymetrix 6.0 arrays.</p></div><div id="S3" class="sec"><h3 id="S3title">Results</h3><p id="P3" class="p p-first-last">We identified SNP rs2268363, located in the follicle stimulating hormone receptor (FSHR) gene, as significantly associated with ED after correcting for multiple comparisons (unadjusted p-value = 5.46×10<sup>−8</sup>; Bonferroni p-value = 0.028). We identified four additional SNPs that tended toward significant association with unadjusted p-value &lt; 10<sup>−06</sup>. Inference of population substructure revealed that cases had a higher proportion of African ancestry compared to controls (77% compared to 60%, p=0.005). A multivariate logistic regression model that incorporated estimated ancestry and four of the top-ranked SNPs was a more accurate classifier of ED than a model that included only clinical variables.</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">Conclusions</h3><p id="P4" class="p p-first-last">To the best of our knowledge, this is the first genome wide association study to identify SNPs associated with adverse effects resulting from radiotherapy. It is important to note that the SNP that proved significantly associated with ED is located within a gene whose encoded product plays a role in male gonad development and function. Another key finding of this project is that the four SNPs most strongly associated with ED were specific to people of African ancestry and would therefore not have been identified had a cohort of European ancestry been screened. This study demonstrates the feasibility of a genome-wide approach to investigate genetic predisposition to radiation injury.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">radiation injury, prostate cancer, genome-wide association study, African American, admixture</span></div></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">Introduction</h2><p id="P5" class="p p-first">Radiotherapy can provide a sustainable cure for prostate cancer and is accepted as a standard treatment option. However, many men develop side effects following radiotherapy, including urinary morbidity, proctitis, and erectile dysfunction (ED), which have a substantial effect on quality of life. Acute symptoms resolve in most patients after a few months, but a subset of patients experience long-term morbidity<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426075">1</a></sup><sup>, </sup><sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426060">2</a></sup>. A method to predict which patients are at greatest risk for permanent side effects would assist both clinicians and patients in weighing the benefits of radiotherapy versus other options of treating localized prostate cancer. Cohort studies have found that some clinical factors such as treatment type, radiation dose, pre-treatment symptoms, age, and co-morbidities, such as diabetes and vascular disease, are associated with developing side effects, but these clinical factors do not fully explain the variability in outcome<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426085">1</a></sup><sup>–</sup><sup><a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426055">4</a></sup>.</p><p id="P6">Research on radiation induced injury in prostate and breast cancer patients suggest that much of the variation in normal tissue damage can be attributed to patient-specific, possibly genetic variation rather than treatment differences or random effects. An initial study examining development of skin telangiectasia among breast cancer patients treated with radiation therapy estimates that 81–90% of variation in normal tissue damage is due to patient-specific characteristics<sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426074">5</a></sup>. Studies among prostate cancer patients have identified single nucleotide polymorphisms (SNPs) in candidate genes, including ATM, LIG4, ERCC2, SOD2, TGFB1, XRCC1, XRCC3, and CYP2D6, among others, that are associated with development of late toxicity in response to radiation therapy<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426056">6</a></sup><sup>–</sup><sup><a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426079">10</a></sup>. SNPs in several of these genes have also been associated with adverse effects in breast cancer patients<sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426069">5</a></sup><sup>, </sup><sup><a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426059">11</a></sup><sup>–</sup><sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426062">14</a></sup>.</p><p id="P7" class="p p-last">To date, research attempting to identify genetic variants associated with radiotherapy side effects has taken a candidate-gene approach, mostly screening genes involved in the DNA damage response. However, conflicting results have been obtained in these studies and no single SNP or group of SNPs has proven to exhibit a consistent association with the development of a normal tissue toxicity following radiotherapy<sup><a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426078">15</a></sup><sup>, </sup><sup><a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426063">16</a></sup>. For this project, we took a broader approach and performed a genome-wide association study (GWAS) with ED as a measure of normal tissue damage experienced by prostate cancer patients treated with external beam radiation therapy (EBRT). This study was also designed to address a health disparity in radiogenomics research in that subjects with primarily European ancestry have constituted the majority of individuals included in these studies. There is growing recognition that the results obtained from one ethnic/racial group are not necessarily applicable to individuals whose ancestry is primarily from a different ethnic/racial group. Thus, the findings in this field of research may not benefit other racial groups if the research is performed primarily with subjects of European background. The research reported in this paper focused on African-American men with the goal to identify the genetic variants specific to this population that may be associated with the development of radiation-induced ED. This study identifies several potentially predictive genetic variants and supports the feasibility of using a genome-wide approach to investigate the genetic predisposition to radiation injury.</p></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">Methods and Materials</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Study Population and Case Definition</h3><p id="P8" class="p p-first-last">A cohort of 138 African American males with adenocarcinoma of the prostate were recruited for this study from the Department of Radiation Oncology of the Elmhurst and Queens Hospital Center affiliated with Mount Sinai School of Medicine between 2001 and 2006. Patients were treated with three dimensional conformal RT or IMRT and received 39–42 fractions of 1.8 Gy. Treatments were delivered with 6 MV or 18 MV photons using a Varian 21 EX linac. Men were followed for an average of 2.8 years (minimum of one year) after treatment to assess development of late-phase ED. ED was assessed using the five-item self-administered Sexual Health Inventory for Men (SHIM) questionnaire<sup><a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426071">17</a></sup>. We categorized SHIM score such that 16 to 25 indicates optimum sexual function, 8 to 15 indicates moderate dysfunction, and 0 to 7 indicates severe dysfunction. All men enrolled in the study filled out the SHIM questionnaire prior to and at least one year after treatment. Only men with an optimum pre-treatment score (≥ 16) were considered for inclusion. Cases were defined as those men with SHIM ≤ 7 after one year post-treatment. Controls were defined as those men with SHIM ≥ 16 after one year post-treatment. A total of 29 men met the case definition for chronic ED and 53 qualified as control subjects. We obtained sufficient quantity and quality of DNA for 27 of the cases and 52 of the controls. At the time of enrollment in the study, clinical data was collected from patient charts relating to disease stage, radiation dosage, and a number of lifestyle factors and co-morbidities that were explored for association with the outcome. The study was approved by the Institutional Review Board of Mount Sinai Medical Center and all individuals provided informed consent prior to blood collection.</p></div><div id="S8" class="sec"><h3 id="S8title">Genotyping and Quality Control</h3><p id="P9" class="p p-first-last">DNA was isolated from lymphocytes using Ficoll separation as described previously<sup><a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426070">18</a></sup>. The DNA was screened for ∼909,000 SNPs using Affymetrix6.0 arrays (Affymetrix, Santa Clara, CA). Birdseed v2 was used to make genotype calls<sup><a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426084">19</a></sup>. The initial genotype call rate among all individuals was 94.5% (range 87.3% to 98.1%). SNPs were excluded from the analysis if they had no genotype for &gt;5% of individuals, were not in Hardy-Weinberg equilibrium among controls (using threshold p &lt;0.001), or had minor allele frequency &lt;5%. The minor allele was defined as the allele with lower frequency among the total sample of 79 individuals. As all individuals were men, heterozygous calls for SNPs on the X chromosome were set to ‘no call’ prior to filtering. The final dataset contained 512,497 SNPs with genotype rate of 99.0%.</p></div><div id="S9" class="sec sec-last"><h3 id="S9title">Data Analysis</h3><p id="P10" class="p p-first">Quality control filtering, identity by state clustering, and association analysis was carried out using the PLINK genetic analysis software<sup><a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426072">20</a></sup>. The main analysis was done using a 2×2 table comparing the frequencies of each of the two alleles (A and a) among cases and controls with a two-sided chi-square test used to assess the statistical significance of the difference in genotype frequency.</p><p id="P11">Population sub-structure was assessed using principle components analysis (PCA) performed in R version 2.10.0<sup><a href="#R21" rid="R21" class=" bibr popnode">21</a></sup>. PCA included a randomly selected subset of 100,000 SNPs for the 79 study subjects as well as 90 individuals from each of three reference populations from the International HapMap Project: European-Americans from Utah, Yorubans from Nigeria, and a combined population from Tokyo, Japan and Beijing, China<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426065">22</a></sup>.</p><p id="P12">Estimation of individual and locus-specific ancestry was performed using the STRUCTURE and MALDsoft programs<sup><a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426076">23</a></sup><sup>, </sup><sup><a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426082">24</a></sup>. A subset of 2,455 ancestry informative markers was selected on the basis of having a greater than 60% minor allele frequency difference between European and African populations from the International HapMap Project<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426080">22</a></sup>. STRUCTURE was run using the admixture model with the number of ancestral populations, K, set to 2. Prior population information from 90 African and 89 European HapMap individuals was included to assist in estimating ancestry. The STRUCTURE run consisted of 10,000 burn-in iterations followed by an additional 10,000 iterations.</p><p id="P13" class="p p-last">General data management and logistic regression modeling was performed using R version 2.10.0<sup><a href="#R21" rid="R21" class=" bibr popnode">21</a></sup>.</p></div></div><div id="S10" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S10title">Results</h2><div id="S11" class="sec sec-first"><h3 id="S11title">Patient Characteristics</h3><p id="P14" class="p p-first-last">Information on demographic, clinical, and life-style factors that may be related to the outcome was compared between cases and controls (<a href="/pmc/articles/PMC2991431/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). A greater proportion of cases reported hypothyroidism compared to controls (11.1% compared to 0; p = 0.014). Cases had on average a slightly higher pre-treatment SHIM score than controls (21 compared to 20, p &lt; 0.001). This trend is opposite that commonly seen among prostate cancer radiotherapy patients but is likely an artifact of the way patients were selected for this study in that the inclusion criteria required all patients to have a pre-treatment score ≥ 16. A greater proportion of controls reported using hormonal therapy than cases, though this difference was not significant (37.3% compared to 22.2%, p = 0.176). A greater proportion of cases had stage III or stage IV prostate cancer compared to controls but again the difference was not statistically significant (7.7% and 11.5% of cases had stage III and stage IV respectively compared to 5.9% and 3.9% of controls, p = 0.406). There were 5 patients who reported using 5-phosphodiesterase inhibitors (PDIs) (3 cases and 2 controls).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="P36">Clinical information for patients.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140624697428000" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th colspan="2" rowspan="1" align="left"></th><th rowspan="1" colspan="1" align="center">Cases</th><th rowspan="1" colspan="1" align="center">Controls</th><th rowspan="1" colspan="1" align="center">p-value<sup>*</sup></th><th rowspan="1" colspan="1" align="center">Total</th></tr><tr><th colspan="2" rowspan="1" align="left"></th><th rowspan="1" colspan="1" align="center">N=27</th><th rowspan="1" colspan="1" align="center">N=52</th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center">N=79</th></tr></thead><tbody><tr><td colspan="2" rowspan="1" align="left">Age in years, mean(sd)</td><td rowspan="1" colspan="1" align="center">64.1 (6.6)</td><td rowspan="1" colspan="1" align="center">64.9 (7.4)</td><td rowspan="1" colspan="1" align="center">0.643</td><td rowspan="1" colspan="1" align="center">64.6 (7.1)</td></tr><tr><td colspan="2" rowspan="1" align="left">Stage, n(%)</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td colspan="2" rowspan="1" align="right">II</td><td rowspan="1" colspan="1" align="center">21 (80.8%)</td><td rowspan="1" colspan="1" align="center">46 (90.2%)</td><td rowspan="2" colspan="1" valign="bottom" align="center">0.406</td><td rowspan="1" colspan="1" align="center">67 (87.0%)</td></tr><tr><td colspan="2" rowspan="1" align="right">III</td><td rowspan="1" colspan="1" align="center">2 (7.7%)</td><td rowspan="1" colspan="1" align="center">3 (5.9%)</td><td rowspan="1" colspan="1" align="center">5 (6.5%)</td></tr><tr><td colspan="2" rowspan="1" align="right">IV</td><td rowspan="1" colspan="1" align="center">3 (11.5%)</td><td rowspan="1" colspan="1" align="center">2 (3.9%)</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">5 (6.5%)</td></tr><tr><td colspan="2" rowspan="1" align="left">Gleason Score, n(%)</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td colspan="2" rowspan="1" align="right">5–6</td><td rowspan="1" colspan="1" align="center">17 (63.0%)</td><td rowspan="1" colspan="1" align="center">31 (59.6%)</td><td rowspan="2" colspan="1" valign="bottom" align="center">0.507</td><td rowspan="1" colspan="1" align="center">48 (60.8%)</td></tr><tr><td colspan="2" rowspan="1" align="right">7</td><td rowspan="1" colspan="1" align="center">4 (14.8%)</td><td rowspan="1" colspan="1" align="center">13 (25.0%)</td><td rowspan="1" colspan="1" align="center">17 (21.5%)</td></tr><tr><td colspan="2" rowspan="1" align="right">8–10</td><td rowspan="1" colspan="1" align="center">6 (22.2%)</td><td rowspan="1" colspan="1" align="center">8 (15.4%)</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">14 (17.7%)</td></tr><tr><td colspan="2" rowspan="1" align="left">EBRT dose (Gy), mean (sd)</td><td rowspan="1" colspan="1" align="center">72.6 (4.3)</td><td rowspan="1" colspan="1" align="center">71.2 (5.9)</td><td rowspan="1" colspan="1" align="center">0.308</td><td rowspan="1" colspan="1" align="center">71.7 (5.4)</td></tr><tr><td colspan="2" rowspan="1" align="left">Follow-up days, mean (sd)</td><td rowspan="1" colspan="1" align="center">981 (288)</td><td rowspan="1" colspan="1" align="center">1068 (279)</td><td rowspan="1" colspan="1" align="center">0.194</td><td rowspan="1" colspan="1" align="center">1038 (284)</td></tr><tr><td colspan="2" rowspan="1" align="left">Hormone therapy<sup>†</sup>, n(%)</td><td rowspan="1" colspan="1" align="center">6 (22.2%)</td><td rowspan="1" colspan="1" align="center">19 (37.3%)</td><td rowspan="1" colspan="1" align="center">0.176</td><td rowspan="1" colspan="1" align="center">25 (31.6%)</td></tr><tr><td colspan="2" rowspan="1" align="left">PD inhibitor use, n(%)</td><td rowspan="1" colspan="1" align="center">3 (11.1%)</td><td rowspan="1" colspan="1" align="center">2 (3.8%)</td><td rowspan="1" colspan="1" align="center">0.208</td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td colspan="2" rowspan="1" align="left">Smoking status, n(%)</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td colspan="2" rowspan="1" align="right">Current or former smoker</td><td rowspan="1" colspan="1" align="center">5 (18.5%)</td><td rowspan="1" colspan="1" align="center">13 (25.0%)</td><td rowspan="1" colspan="1" align="center">0.515</td><td rowspan="1" colspan="1" align="center">18 (22.8%)</td></tr><tr><td colspan="2" rowspan="1" align="right">Never smoker</td><td rowspan="1" colspan="1" align="center">22 (81.5%)</td><td rowspan="1" colspan="1" align="center">39 (75.0%)</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">61 (77.2%)</td></tr><tr><td colspan="2" rowspan="1" align="left">Diabetes, n(%)</td><td rowspan="1" colspan="1" align="center">6 (22.2%)</td><td rowspan="1" colspan="1" align="center">10 (20.2%)</td><td rowspan="1" colspan="1" align="center">0.819</td><td rowspan="1" colspan="1" align="center">16 (20.8%)</td></tr><tr><td colspan="2" rowspan="1" align="left">Heavy alcohol use, n(%)</td><td rowspan="1" colspan="1" align="center">2 (7.4%)</td><td rowspan="1" colspan="1" align="center">4 (7.7%)</td><td rowspan="1" colspan="1" align="center">0.964</td><td rowspan="1" colspan="1" align="center">6 (7.6%)</td></tr><tr><td colspan="2" rowspan="1" align="left">Arthritis, n(%)</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">5 (9.6%)</td><td rowspan="1" colspan="1" align="center">0.096</td><td rowspan="1" colspan="1" align="center">5 (6.3%)</td></tr><tr><td colspan="2" rowspan="1" align="left">Asthma, n(%)</td><td rowspan="1" colspan="1" align="center">3 (11.1%)</td><td rowspan="1" colspan="1" align="center">4 (7.7%)</td><td rowspan="1" colspan="1" align="center">0.612</td><td rowspan="1" colspan="1" align="center">7 (8.9%)</td></tr><tr><td colspan="2" rowspan="1" align="left">Heart Disease, n(%)</td><td rowspan="1" colspan="1" align="center">1 (3.7%)</td><td rowspan="1" colspan="1" align="center">7 (13.5%)</td><td rowspan="1" colspan="1" align="center">0.173</td><td rowspan="1" colspan="1" align="center">8 (10.1%)</td></tr><tr><td colspan="2" rowspan="1" align="left">Hypertension, n(%)</td><td rowspan="1" colspan="1" align="center">16 (59.3%)</td><td rowspan="1" colspan="1" align="center">31 (59.6%)</td><td rowspan="1" colspan="1" align="center">0.976</td><td rowspan="1" colspan="1" align="center">47 (59.5%)</td></tr><tr><td colspan="2" rowspan="1" align="left">Stroke, n(%)</td><td rowspan="1" colspan="1" align="center">1 (3.7%)</td><td rowspan="1" colspan="1" align="center">2 (3.8%)</td><td rowspan="1" colspan="1" align="center">0.975</td><td rowspan="1" colspan="1" align="center">3 (3.8%)</td></tr><tr><td colspan="2" rowspan="1" align="left">Emphysema, n(%)</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">1 (1.9%)</td><td rowspan="1" colspan="1" align="center">0.468</td><td rowspan="1" colspan="1" align="center">1 (1.3%)</td></tr><tr><td colspan="2" rowspan="1" align="left">Gout , n(%)</td><td rowspan="1" colspan="1" align="center">1 (3.7%)</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.163</td><td rowspan="1" colspan="1" align="center">1 (1.3%)</td></tr><tr><td colspan="2" rowspan="1" align="left">Hypothyroidism, n(%)</td><td rowspan="1" colspan="1" align="center">3 (11.1%)</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.014</td><td rowspan="1" colspan="1" align="center">3 (3.8%)</td></tr><tr><td colspan="2" rowspan="1" align="left">Glaucoma, n(%)</td><td rowspan="1" colspan="1" align="center">2 (7.4%)</td><td rowspan="1" colspan="1" align="center">2 (3.8%)</td><td rowspan="1" colspan="1" align="center">0.493</td><td rowspan="1" colspan="1" align="center">4 (5.1%)</td></tr><tr><td colspan="2" rowspan="1" align="left">Pre-treatment SHIM score, mean(sd)</td><td rowspan="1" colspan="1" align="center">21 (2.7)</td><td rowspan="1" colspan="1" align="center">20 (2.8)</td><td rowspan="1" colspan="1" align="center">&lt; 0.001</td><td rowspan="1" colspan="1" align="center">20 (2.8)</td></tr></tbody></table></div><div id="largeobj_idm140624697428000" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC2991431/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><sup>*</sup>Chi-square test was used for categorical variables and one-way ANOVA was used for continuous variables</div><div id="TFN2"><sup>†</sup>22 individuals reported taking leuprolide, 1 individual reported taking leuprolide and bicalutamide, 1 individual reported taking nilutamide, 1 individual was missing details of drug type.</div></div></div></div><div id="S12" class="sec"><h3 id="S12title">Genome-Wide Association Test</h3><p id="P15" class="p p-first">We performed allelic association tests to compare the allele frequencies for 512,497 SNPs between cases and controls (<a href="/pmc/articles/PMC2991431/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). One SNP was identified, rs2268363 located in the follicle-stimulating hormone receptor (FSHR) gene on chromosome 2, that was significantly associated with ED after correcting for multiple comparisons (unadjusted p-value = 5.46×10<sup>−8</sup>; Bonferroni corrected p-value = 0.028; <a href="/pmc/articles/PMC2991431/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). Men possessing the minor allele of rs2268363 had seven-fold increased odds of developing post-radiotherapy ED compared to men who did not possess this SNP (OR = 7.03; 95% CI 3.4–14.7).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC2991431/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140624768915744" class="figure"><a href="/pmc/articles/PMC2991431/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2991431_nihms225345f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms225345f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2991431/bin/nihms225345f1.jpg"></a></div><div id="largeobj_idm140624768915744" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2991431/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC2991431/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="P31">Plot of -log<sub>10</sub> p-values from allelic chi-square tests for association of each of 512,497 SNPs with development of post-radiotherapy ED.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="P39">SNPs showing the strongest association (p-value &lt; 10<sup>−05</sup>) with development of ED following radiotherapy. Minor allele identity is based on all 79 individuals. Chr, chromosome; BP, base pair; MAF, minor allele frequency; CEU, European-American HapMap population; YRI, African HapMap population.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140624768931120" class="xtable"><table frame="hsides" rules="rows" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="bottom" align="center">SNP</th><th rowspan="1" colspan="1" valign="bottom" align="center">Chr</th><th rowspan="1" colspan="1" valign="bottom" align="center">BP Position</th><th rowspan="1" colspan="1" valign="bottom" align="center">Nearest Gene</th><th rowspan="1" colspan="1" valign="bottom" align="center">Distance to<br>Gene (BP)</th><th rowspan="1" colspan="1" valign="bottom" align="center">MAF<br>Cases</th><th rowspan="1" colspan="1" valign="bottom" align="center">MAF<br>Controls</th><th rowspan="1" colspan="1" valign="bottom" align="center">p-value</th><th rowspan="1" colspan="1" valign="bottom" align="center">Odds<br>Ratio</th><th rowspan="1" colspan="1" valign="bottom" align="center">Bonferroni<br>p-value</th><th rowspan="1" colspan="1" valign="bottom" align="center">Ancestry<br>adjusted<br>p-value</th><th rowspan="1" colspan="1" valign="bottom" align="center">MAF<br>CEU</th><th rowspan="1" colspan="1" valign="bottom" align="center">MAF<br>YRI</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="center">rs2268363</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">49054832</td><td rowspan="1" colspan="1" align="center">FSHR</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.611</td><td rowspan="1" colspan="1" align="center">0.183</td><td rowspan="1" colspan="1" align="center">5.46×10<sup>−08</sup></td><td rowspan="1" colspan="1" align="center">7.03</td><td rowspan="1" colspan="1" align="center">0.028</td><td rowspan="1" colspan="1" align="center">1.98 ×10<sup>−04</sup></td><td rowspan="1" colspan="1" align="center">0.1</td><td rowspan="1" colspan="1" align="center">0.592</td></tr><tr><td rowspan="1" colspan="1" align="center">rs10194115</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">47093516</td><td rowspan="1" colspan="1" align="center">TTC7A</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.404</td><td rowspan="1" colspan="1" align="center">0.07</td><td rowspan="1" colspan="1" align="center">4.73×10<sup>−07</sup></td><td rowspan="1" colspan="1" align="center">9.00</td><td rowspan="1" colspan="1" align="center">0.242</td><td rowspan="1" colspan="1" align="center">9.39 ×10<sup>−05</sup></td><td rowspan="1" colspan="1" align="center">0.033</td><td rowspan="1" colspan="1" align="center">0.242</td></tr><tr><td rowspan="1" colspan="1" align="center">rs2806864<sup>*</sup></td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">117271304</td><td rowspan="1" colspan="1" align="center">PTGFRN</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.537</td><td rowspan="1" colspan="1" align="center">0.153</td><td rowspan="1" colspan="1" align="center">5.86×10<sup>−07</sup></td><td rowspan="1" colspan="1" align="center">6.42</td><td rowspan="1" colspan="1" align="center">0.300</td><td rowspan="1" colspan="1" align="center">7.15 ×10<sup>−04</sup></td><td rowspan="1" colspan="1" align="center">0.017</td><td rowspan="1" colspan="1" align="center">0.533</td></tr><tr><td rowspan="1" colspan="1" align="center">rs7064929</td><td rowspan="1" colspan="1" align="center">23</td><td rowspan="1" colspan="1" align="center">64283744</td><td rowspan="1" colspan="1" align="center">KIAA1166</td><td rowspan="1" colspan="1" align="center">170683</td><td rowspan="1" colspan="1" align="center">0.741</td><td rowspan="1" colspan="1" align="center">0.173</td><td rowspan="1" colspan="1" align="center">6.88 ×10<sup>−07</sup></td><td rowspan="1" colspan="1" align="center">13.65</td><td rowspan="1" colspan="1" align="center">0.352</td><td rowspan="1" colspan="1" align="center">8.57 ×10<sup>−05</sup></td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.971</td></tr><tr><td rowspan="1" colspan="1" align="center">rs10861905</td><td rowspan="1" colspan="1" align="center">12</td><td rowspan="1" colspan="1" align="center">107291463</td><td rowspan="1" colspan="1" align="center">CMKLR1</td><td rowspan="1" colspan="1" align="center">34247</td><td rowspan="1" colspan="1" align="center">0.259</td><td rowspan="1" colspan="1" align="center">0.010</td><td rowspan="1" colspan="1" align="center">8.33 ×10<sup>−07</sup></td><td rowspan="1" colspan="1" align="center">33.95</td><td rowspan="1" colspan="1" align="center">0.427</td><td rowspan="1" colspan="1" align="center">0.00145</td><td rowspan="1" colspan="1" align="center">0.033</td><td rowspan="1" colspan="1" align="center">0.1</td></tr><tr><td rowspan="1" colspan="1" align="center">rs1527243</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">123007492</td><td rowspan="1" colspan="1" align="center">TSN</td><td rowspan="1" colspan="1" align="center">765594</td><td rowspan="1" colspan="1" align="center">0.167</td><td rowspan="1" colspan="1" align="center">0.57</td><td rowspan="1" colspan="1" align="center">1.39 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">0.15</td><td rowspan="1" colspan="1" align="center">0.713</td><td rowspan="1" colspan="1" align="center">0.00141</td><td rowspan="1" colspan="1" align="center">0.85</td><td rowspan="1" colspan="1" align="center">0.233</td></tr><tr><td rowspan="1" colspan="1" align="center">rs12336160</td><td rowspan="1" colspan="1" align="center">9</td><td rowspan="1" colspan="1" align="center">33273582</td><td rowspan="1" colspan="1" align="center">CHMP5</td><td rowspan="1" colspan="1" align="center">2066</td><td rowspan="1" colspan="1" align="center">0.407</td><td rowspan="1" colspan="1" align="center">0.087</td><td rowspan="1" colspan="1" align="center">1.46 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">7.26</td><td rowspan="1" colspan="1" align="center">0.746</td><td rowspan="1" colspan="1" align="center">1.36 ×10<sup>−04</sup></td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.25</td></tr><tr><td rowspan="1" colspan="1" align="center">rs2716734</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">39801225</td><td rowspan="1" colspan="1" align="center">TMEM178</td><td rowspan="1" colspan="1" align="center">2618</td><td rowspan="1" colspan="1" align="center">0.482</td><td rowspan="1" colspan="1" align="center">0.135</td><td rowspan="1" colspan="1" align="center">1.98 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">5.97</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">7.35 ×10<sup>−04</sup></td><td rowspan="1" colspan="1" align="center">0.025</td><td rowspan="1" colspan="1" align="center">0.375</td></tr><tr><td rowspan="1" colspan="1" align="center">rs10210358</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">141512090</td><td rowspan="1" colspan="1" align="center">LRP1B</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.704</td><td rowspan="1" colspan="1" align="center">0.308</td><td rowspan="1" colspan="1" align="center">2.01 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">5.34</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">3.36 ×10<sup>−04</sup></td><td rowspan="1" colspan="1" align="center">0.15</td><td rowspan="1" colspan="1" align="center">0.658</td></tr><tr><td rowspan="1" colspan="1" align="center">rs16861326</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">18167074</td><td rowspan="1" colspan="1" align="center">IGSF21</td><td rowspan="1" colspan="1" align="center">139753</td><td rowspan="1" colspan="1" align="center">0.259</td><td rowspan="1" colspan="1" align="center">0.019</td><td rowspan="1" colspan="1" align="center">2.10 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">17.85</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">4.36 ×10<sup>−04</sup></td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.108</td></tr><tr><td rowspan="1" colspan="1" align="center">rs5925696</td><td rowspan="1" colspan="1" align="center">23</td><td rowspan="1" colspan="1" align="center">22801998</td><td rowspan="1" colspan="1" align="center">DDX53</td><td rowspan="1" colspan="1" align="center">126010</td><td rowspan="1" colspan="1" align="center">0.815</td><td rowspan="1" colspan="1" align="center">0.26</td><td rowspan="1" colspan="1" align="center">3.08 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">12.52</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">1.24 ×10<sup>−04</sup></td><td rowspan="1" colspan="1" align="center">0.7</td><td rowspan="1" colspan="1" align="center">0.817</td></tr><tr><td rowspan="1" colspan="1" align="center">rs7552382</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">117324524</td><td rowspan="1" colspan="1" align="center">PTGFRN</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.611</td><td rowspan="1" colspan="1" align="center">0.235</td><td rowspan="1" colspan="1" align="center">3.53 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">5.11</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">3.51 ×10<sup>−04</sup></td><td rowspan="1" colspan="1" align="center">0.283</td><td rowspan="1" colspan="1" align="center">0.512</td></tr><tr><td rowspan="1" colspan="1" align="center">rs6741148</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">38131336</td><td rowspan="1" colspan="1" align="center">FAM82A1</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.722</td><td rowspan="1" colspan="1" align="center">0.333</td><td rowspan="1" colspan="1" align="center">3.64 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">5.2</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">0.00198</td><td rowspan="1" colspan="1" align="center">0.042</td><td rowspan="1" colspan="1" align="center">0.733</td></tr><tr><td rowspan="1" colspan="1" align="center">rs3802458<sup>†</sup></td><td rowspan="1" colspan="1" align="center">9</td><td rowspan="1" colspan="1" align="center">96781095</td><td rowspan="1" colspan="1" align="center">C9orf3</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.296</td><td rowspan="1" colspan="1" align="center">0.039</td><td rowspan="1" colspan="1" align="center">3.78 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">10.53</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">3.23 ×10<sup>−04</sup></td><td rowspan="1" colspan="1" align="center">0.008</td><td rowspan="1" colspan="1" align="center">0.192</td></tr><tr><td rowspan="1" colspan="1" align="center">rs6862844</td><td rowspan="1" colspan="1" align="center">5</td><td rowspan="1" colspan="1" align="center">124393866</td><td rowspan="1" colspan="1" align="center">ZNF608</td><td rowspan="1" colspan="1" align="center">285162</td><td rowspan="1" colspan="1" align="center">0.389</td><td rowspan="1" colspan="1" align="center">0.087</td><td rowspan="1" colspan="1" align="center">4.31 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">6.72</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">9.08 ×10<sup>−04</sup></td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.233</td></tr><tr><td rowspan="1" colspan="1" align="center">rs10993429<sup>†</sup></td><td rowspan="1" colspan="1" align="center">9</td><td rowspan="1" colspan="1" align="center">96779286</td><td rowspan="1" colspan="1" align="center">C9orf3</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.315</td><td rowspan="1" colspan="1" align="center">0.048</td><td rowspan="1" colspan="1" align="center">4.36 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">9.10</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">0.00107</td><td rowspan="1" colspan="1" align="center">0.008</td><td rowspan="1" colspan="1" align="center">0.192</td></tr><tr><td rowspan="1" colspan="1" align="center">rs2901964</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">15665013</td><td rowspan="1" colspan="1" align="center">ELA2A</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.241</td><td rowspan="1" colspan="1" align="center">0.625</td><td rowspan="1" colspan="1" align="center">4.60 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">0.19</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">2.34 ×10<sup>−04</sup></td><td rowspan="1" colspan="1" align="center">0.783</td><td rowspan="1" colspan="1" align="center">0.225</td></tr><tr><td rowspan="1" colspan="1" align="center">rs11122834</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">121417759</td><td rowspan="1" colspan="1" align="center">GLI2</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.667</td><td rowspan="1" colspan="1" align="center">0.289</td><td rowspan="1" colspan="1" align="center">4.83 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">4.93</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">0.00205</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.6</td></tr><tr><td rowspan="1" colspan="1" align="center">rs9948</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">96864527</td><td rowspan="1" colspan="1" align="center">CNNM3</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.685</td><td rowspan="1" colspan="1" align="center">0.308</td><td rowspan="1" colspan="1" align="center">5.69 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">4.90</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">0.00133</td><td rowspan="1" colspan="1" align="center">0.083</td><td rowspan="1" colspan="1" align="center">0.583</td></tr><tr><td rowspan="1" colspan="1" align="center">rs5965182</td><td rowspan="1" colspan="1" align="center">23</td><td rowspan="1" colspan="1" align="center">65523418</td><td rowspan="1" colspan="1" align="center">HEPH</td><td rowspan="1" colspan="1" align="center">119463</td><td rowspan="1" colspan="1" align="center">0.615</td><td rowspan="1" colspan="1" align="center">0.12</td><td rowspan="1" colspan="1" align="center">6.25 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">11.73</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">4.28 ×10<sup>−04</sup></td><td rowspan="1" colspan="1" align="center">0.183</td><td rowspan="1" colspan="1" align="center">0.55</td></tr><tr><td rowspan="1" colspan="1" align="center">rs17005499</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">121425911</td><td rowspan="1" colspan="1" align="center">GLI2</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.596</td><td rowspan="1" colspan="1" align="center">0.231</td><td rowspan="1" colspan="1" align="center">6.70 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">4.92</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">0.00316</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.492</td></tr><tr><td rowspan="1" colspan="1" align="center">rs943371<sup>*</sup></td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">117269213</td><td rowspan="1" colspan="1" align="center">PTGFRN</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.558</td><td rowspan="1" colspan="1" align="center">0.202</td><td rowspan="1" colspan="1" align="center">7.17 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">4.98</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">0.00167</td><td rowspan="1" colspan="1" align="center">0.017</td><td rowspan="1" colspan="1" align="center">0.533</td></tr><tr><td rowspan="1" colspan="1" align="center">rs5944185</td><td rowspan="1" colspan="1" align="center">23</td><td rowspan="1" colspan="1" align="center">25763535</td><td rowspan="1" colspan="1" align="center">MAGEB18</td><td rowspan="1" colspan="1" align="center">302849</td><td rowspan="1" colspan="1" align="center">0.667</td><td rowspan="1" colspan="1" align="center">0.16</td><td rowspan="1" colspan="1" align="center">7.26 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">10.50</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">2.46 ×10<sup>−04</sup></td><td rowspan="1" colspan="1" align="center">0.25</td><td rowspan="1" colspan="1" align="center">0.667</td></tr><tr><td rowspan="1" colspan="1" align="center">rs219553</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">21431248</td><td rowspan="1" colspan="1" align="center">APOB</td><td rowspan="1" colspan="1" align="center">310798</td><td rowspan="1" colspan="1" align="center">0.204</td><td rowspan="1" colspan="1" align="center">0.582</td><td rowspan="1" colspan="1" align="center">7.30 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">0.18</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">0.00151</td><td rowspan="1" colspan="1" align="center">0.783</td><td rowspan="1" colspan="1" align="center">0.233</td></tr><tr><td rowspan="1" colspan="1" align="center">rs6049375</td><td rowspan="1" colspan="1" align="center">20</td><td rowspan="1" colspan="1" align="center">24006407</td><td rowspan="1" colspan="1" align="center">GGTLC1</td><td rowspan="1" colspan="1" align="center">88991</td><td rowspan="1" colspan="1" align="center">0.648</td><td rowspan="1" colspan="1" align="center">0.276</td><td rowspan="1" colspan="1" align="center">7.68 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">4.84</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">0.00124</td><td rowspan="1" colspan="1" align="center">0.058</td><td rowspan="1" colspan="1" align="center">0.717</td></tr><tr><td rowspan="1" colspan="1" align="center">rs5971305</td><td rowspan="1" colspan="1" align="center">23</td><td rowspan="1" colspan="1" align="center">28142974</td><td rowspan="1" colspan="1" align="center">WDR42B</td><td rowspan="1" colspan="1" align="center">233487</td><td rowspan="1" colspan="1" align="center">0.407</td><td rowspan="1" colspan="1" align="center">0.02</td><td rowspan="1" colspan="1" align="center">7.74 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">33.69</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">0.00117</td><td rowspan="1" colspan="1" align="center">0.3</td><td rowspan="1" colspan="1" align="center">0.233</td></tr><tr><td rowspan="1" colspan="1" align="center">rs2806863<sup>*</sup></td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">117271036</td><td rowspan="1" colspan="1" align="center">PTGFRN</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.537</td><td rowspan="1" colspan="1" align="center">0.192</td><td rowspan="1" colspan="1" align="center">8.86 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">4.87</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">0.00208</td><td rowspan="1" colspan="1" align="center">0.017</td><td rowspan="1" colspan="1" align="center">0.533</td></tr><tr><td rowspan="1" colspan="1" align="center">rs872690</td><td rowspan="1" colspan="1" align="center">23</td><td rowspan="1" colspan="1" align="center">37739671</td><td rowspan="1" colspan="1" align="center">SYTL5</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.259</td><td rowspan="1" colspan="1" align="center">0.029</td><td rowspan="1" colspan="1" align="center">9.29 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">11.78</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">0.02662</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.1</td></tr><tr><td rowspan="1" colspan="1" align="center">rs13408245</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">122183723</td><td rowspan="1" colspan="1" align="center">MKI67IP</td><td rowspan="1" colspan="1" align="center">17301</td><td rowspan="1" colspan="1" align="center">0.482</td><td rowspan="1" colspan="1" align="center">0.154</td><td rowspan="1" colspan="1" align="center">9.80 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">5.10</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">0.00327</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0.342</td></tr><tr><td rowspan="1" colspan="1" align="center">rs6432484</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">14944498</td><td rowspan="1" colspan="1" align="center">FAM84A</td><td rowspan="1" colspan="1" align="center">250600</td><td rowspan="1" colspan="1" align="center">0.596</td><td rowspan="1" colspan="1" align="center">0.235</td><td rowspan="1" colspan="1" align="center">9.88 ×10<sup>−06</sup></td><td rowspan="1" colspan="1" align="center">4.80</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">0.00490</td><td rowspan="1" colspan="1" align="center">0.125</td><td rowspan="1" colspan="1" align="center">0.558</td></tr></tbody></table></div><div id="largeobj_idm140624768931120" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC2991431/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN3"><sup>*</sup>and</div><div id="TFN4"><sup>†</sup>SNPs in linkage disequilibrium with r<sup>2</sup>&gt;0.8</div></div></div><p id="P16" class="p p-last">Several other SNPs were associated with ED upon initial statistical testing, but p-values for these associations increased above the threshold of significance after applying the conservative Bonferroni correction for multiple comparisons (<a href="/pmc/articles/PMC2991431/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). The second top-ranking SNP, rs10194115, lies within the coding region of the tetratricopeptide repeat domain 7A (TTC7A) gene and is associated with a nine-fold increased odds of developing post-radiotherapy ED (unadjusted p-value = 4.73×10<sup>−7</sup>, OR = 9.00, 95% CI 3.5–23.2). The third top-ranking SNP and three additional high-ranking SNPs (p-value less than 10<sup>−05</sup>), are located within the prostaglandin F2 receptor negative regulator (PTGFRN) gene and are associated with between 4.9- and 6.4-fold increased odds of developing post-radiotherapy ED (<a href="/pmc/articles/PMC2991431/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>).</p></div><div id="S13" class="sec"><h3 id="S13title">Identification of Population Sub-Structure and Association of African Ancestry with Radiotherapy Side Effects</h3><p id="P17" class="p p-first">During our initial quality control analyses, we observed that there may be underlying population sub-structure among our patient population. Identity by state (IBS) clustering discerned 6 clusters of individuals who may be more genetically similar to each other than to the rest of the individuals. Permutation testing of IBS distances suggests that cases may be genetically more similar to other cases than to controls (p = 0.003). This was not surprising given that this cohort consists of self-identified African Americans, each person with varying degrees of admixture of African and European ancestors. Population stratification (i.e. mismatch of ancestry in cases and controls) is a common confounder in GWAS. To further explore a potential role of ancestry in our association results, we sought to estimate the proportion of each individual's ancestry that came from African versus European progenitors for adjustment in association tests.</p><p id="P18">To visualize the genetic patterns of our cohort and their expected ancestral populations, we performed principle components analysis (PCA) of our patients together with three groups of individuals genotyped by the International HapMap project (European-Americans, Africans, and Asians)<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426067">22</a></sup>. The PCA plot demonstrates that our patient cohort falls between the European and African clusters, as expected for African American individuals (<a href="/pmc/articles/PMC2991431/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>). Interestingly, the cases appear to cluster nearer to the African HapMap population compared to the controls. We found a statistically significant difference in principle components (PC) coordinate values between ED cases and controls (p = 0.004 for PC1; p = 0.003 for PC2), suggesting an underlying genetic difference between cases and controls.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC2991431/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140624696370352" class="figure"><a href="/pmc/articles/PMC2991431/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2991431_nihms225345f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms225345f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2991431/bin/nihms225345f2.jpg"></a></div><div id="largeobj_idm140624696370352" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2991431/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC2991431/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="P32">Principle Components Analysis using 100,000 SNPs randomly selected from the 512,497 SNPs used in the association test. Includes 27 ED cases, 52 controls, and 90 HapMap individuals from each of three reference populations: Asian, African, and European.</p></div></div></div><p id="P19">The program STRUCTURE was used to estimate the proportion of African ancestry for each individual using a set of 2,455 ancestry-informative SNPs. As this cohort has self-identified as African American, we assumed two ancestral populations, African and European. The STRUCTURE analysis accurately grouped the HapMap individuals into two populations with our African American cohort sharing some proportion of their SNPs with both ancestral populations (<a href="/pmc/articles/PMC2991431/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3A</span></a>). In agreement with the principle components analysis, the STRUCTURE estimate suggests that, on average, ED cases have a greater proportion of African ancestry compared to controls. Among ED cases, the average proportion ancestry shared with the African HapMap population is 77% compared with 60% for the ED controls (p = 0.005). Using the estimates from the STRUCTURE model, we used the MALDsoft program to calculate the average proportion ancestry among cases or controls at each locus in the genome. The MALDsoft analysis shows that at any given locus, cases have a greater proportion of African ancestry than controls (<a href="/pmc/articles/PMC2991431/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3B</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC2991431/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140624691704800" class="figure"><a href="/pmc/articles/PMC2991431/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2991431_nihms225345f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms225345f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2991431/bin/nihms225345f3.jpg"></a></div><div id="largeobj_idm140624691704800" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC2991431/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC2991431/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="P33">(A) STRUCTURE analysis showing average individual ancestry using 2,455 ancestry-informative markers (AIMs), and (B) MALDsoft locus-specific average ancestry among cases and controls.</p></div></div></div><p id="P20" class="p p-last">Based on this evidence of population stratification and its association with our outcome, we tested for association between genotype and ED using logistic regression to adjust for individual estimated ancestry (<a href="/pmc/articles/PMC2991431/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>, column 9). All SNPs with un-corrected p-value less than 10<sup>−06</sup> were still significantly (p&lt;0.05) associated with development of ED, although the p-values did increase for most SNPs after adjusting for proportion of African ancestry.</p></div><div id="S14" class="sec sec-last"><h3 id="S14title">Classification of Radiotherapy Patients Based on Clinical and Genetic Factors</h3><p id="P21" class="p p-first">Logistic regression models were used to investigate the utility of genetic and clinical factors for the classification of radiotherapy patients according to development of ED following treatment. In a model including clinical covariates for which sufficient data was available, only pre-treatment SHIM score is significantly associated with developing ED (<a href="/pmc/articles/PMC2991431/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). After controlling for all other covariates, a one-point higher pre-treatment SHIM score is associated with an odds ratio of 1.3 for developing ED (p = 0.016). Again, this association may be an artifact of the inclusion criteria for this study. We did not find any significant association between age at diagnosis, stage, Gleason score, EBRT dose, hormone use, length of follow-up, smoking status, diabetes, hypertension, or asthma with development of ED, either alone or in a multivariate model (<a href="/pmc/articles/PMC2991431/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). We should note that given the small sample size of this study, the numbers of individuals reporting many of the covariates investigated in this model are small, even after excluding some covariates (<a href="/pmc/articles/PMC2991431/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="P42">Logistic regression model of effects of clinical variables on post-radiotherapy ED.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140624686252480" class="xtable"><table frame="hsides" rules="none" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="right"></th><th colspan="2" rowspan="1" align="center">Univariate Analysis</th><th colspan="2" rowspan="1" align="center">Multivariate Analysis<sup>#</sup></th></tr><tr><th colspan="5" rowspan="1" valign="bottom" align="right"><hr></th></tr><tr><th rowspan="1" colspan="1" align="right"></th><th rowspan="1" colspan="1" align="center"><span class="underline">Odds Ratio</span></th><th rowspan="1" colspan="1" align="center"><span class="underline">p-value</span></th><th rowspan="1" colspan="1" align="center"><span class="underline">Odds Ratio</span></th><th rowspan="1" colspan="1" align="center"><span class="underline">p-value</span></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="right"><strong>Age at diagnosis</strong></td><td rowspan="1" colspan="1" align="center">0.98</td><td rowspan="1" colspan="1" align="center">0.639</td><td rowspan="1" colspan="1" align="center">1.02</td><td rowspan="1" colspan="1" align="center">0.732</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>Prostate cancer stage</strong></td><td rowspan="1" colspan="1" align="center">1.74</td><td rowspan="1" colspan="1" align="center">0.201</td><td rowspan="1" colspan="1" align="center">2.16</td><td rowspan="1" colspan="1" align="center">0.164</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>Gleason Score</strong></td><td rowspan="1" colspan="1" align="center">1.06</td><td rowspan="1" colspan="1" align="center">0.849</td><td rowspan="1" colspan="1" align="center">1.05</td><td rowspan="1" colspan="1" align="center">0.910</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>EBRT Dose</strong></td><td rowspan="1" colspan="1" align="center">1.00</td><td rowspan="1" colspan="1" align="center">0.316</td><td rowspan="1" colspan="1" align="center">1.00</td><td rowspan="1" colspan="1" align="center">0.360</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>Hormone use</strong></td><td rowspan="1" colspan="1" align="center">0.48</td><td rowspan="1" colspan="1" align="center">0.180</td><td rowspan="1" colspan="1" align="center">0.43</td><td rowspan="1" colspan="1" align="center">0.228</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>Pre-treatment SHIM score</strong></td><td rowspan="1" colspan="1" align="center">1.20</td><td rowspan="1" colspan="1" align="center">0.040</td><td rowspan="1" colspan="1" align="center">1.29</td><td rowspan="1" colspan="1" align="center">0.016</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>Follow-up time</strong></td><td rowspan="1" colspan="1" align="center">1.00</td><td rowspan="1" colspan="1" align="center">0.195</td><td rowspan="1" colspan="1" align="center">1.00</td><td rowspan="1" colspan="1" align="center">0.157</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>Diabetes</strong></td><td rowspan="1" colspan="1" align="center">1.14</td><td rowspan="1" colspan="1" align="center">0.819</td><td rowspan="1" colspan="1" align="center">1.68</td><td rowspan="1" colspan="1" align="center">0.471</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>Hypertension</strong></td><td rowspan="1" colspan="1" align="center">0.99</td><td rowspan="1" colspan="1" align="center">0.976</td><td rowspan="1" colspan="1" align="center">0.62</td><td rowspan="1" colspan="1" align="center">0.453</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>Asthma</strong></td><td rowspan="1" colspan="1" align="center">1.50</td><td rowspan="1" colspan="1" align="center">0.614</td><td rowspan="1" colspan="1" align="center">2.14</td><td rowspan="1" colspan="1" align="center">0.413</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>Smoking status</strong></td><td rowspan="1" colspan="1" align="center">0.68</td><td rowspan="1" colspan="1" align="center">0.516</td><td rowspan="1" colspan="1" align="center">0.92</td><td rowspan="1" colspan="1" align="center">0.905</td></tr></tbody></table></div><div id="largeobj_idm140624686252480" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2991431/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN5"><sup>#</sup>adjusting for all other covariates listed</div></div></div><p id="P22">We next developed a logistic regression model including genetic factors to classify patients in terms of developing ED. We included the five SNPs with chi-square association p-values less than 10<sup>−6</sup> as well as proportion African ancestry. We also included pre-treatment SHIM score, as that was associated with ED in the clinical model. Pre-treatment SHIM score as well as SNP rs7064929 were no longer significantly associated with developing ED once the other SNPs were included (p = 0.8682 for rs7064929 and p = 0.0671 for pre-treatment SHIM score), so we excluded these variables from the final regression model. Proportion African ancestry was no longer significantly associated with development of ED once the SNPs were included (p = 0.3584), however inclusion of ancestry controls for population stratification and modifies the strength of association between the SNPs and ED, so it was retained in the final model. The final model included proportion African ancestry, and four of the most strongly associated SNPs (<a href="/pmc/articles/PMC2991431/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>). We should note that given the relatively small sample size for this study, the odds ratios associated with the SNPs in this model are imprecise measurements and warrant replication in a larger cohort. Among these four SNPs, a greater percentage of cases were homozygous for more than one risk allele compared to controls (<a href="/pmc/articles/PMC2991431/table/T5/" target="table" class="fig-table-link figpopup" rid-figpopup="T5" rid-ob="ob-T5" co-legend-rid=""><span>Table 5</span></a>). Similarly, a greater percentage of cases were heterozygous for more than one risk allele compared to controls. This suggests that it may be informative to use a combination of SNPs to formulate a predictive model.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T4"><h3>Table 4</h3><!--caption a7--><div class="caption"><p id="P44">Logistic regression model of effects of genetic variables on post-radiotherapy ED.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140624698713920" class="xtable"><table frame="hsides" rules="none" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="right"></th><th colspan="2" rowspan="1" align="center">Multivariate Analysis<sup>#</sup></th></tr><tr><th colspan="3" rowspan="1" valign="bottom" align="right"><hr></th></tr><tr><th rowspan="1" colspan="1" align="right"></th><th rowspan="1" colspan="1" align="center"><span class="underline">Odds Ratio</span></th><th rowspan="1" colspan="1" align="center"><span class="underline">p-value</span></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="right"><strong>rs2268363</strong></td><td rowspan="1" colspan="1" align="center">20.01</td><td rowspan="1" colspan="1" align="center">0.006</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>rs10194115</strong></td><td rowspan="1" colspan="1" align="center">33.12</td><td rowspan="1" colspan="1" align="center">0.013</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>rs2806864</strong></td><td rowspan="1" colspan="1" align="center">11.09</td><td rowspan="1" colspan="1" align="center">0.014</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>rs10861905</strong></td><td rowspan="1" colspan="1" align="center">107.45</td><td rowspan="1" colspan="1" align="center">0.006</td></tr><tr><td rowspan="1" colspan="1" align="right"><strong>African ancestry</strong></td><td rowspan="1" colspan="1" align="center">0.459</td><td rowspan="1" colspan="1" align="center">0.765</td></tr></tbody></table></div><div id="largeobj_idm140624698713920" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2991431/table/T4/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN6"><sup>#</sup>adjusting for all other covariates listed</div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T5"><h3>Table 5</h3><!--caption a7--><div class="caption"><p id="P46">Prevalence of risk alleles among cases and controls.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140624685496672" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="right"></th><th rowspan="1" colspan="1" align="center">Cases N = 27<sup>*</sup></th><th rowspan="1" colspan="1" align="center">Controls N = 52<sup>*</sup></th></tr><tr><th rowspan="1" colspan="1" align="right"></th><th rowspan="1" colspan="1" align="center">N(%)</th><th rowspan="1" colspan="1" align="center">N(%)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="right">Homozygous for high-risk allele:</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="right">1 SNP</td><td rowspan="1" colspan="1" align="center">14 (51.9%)</td><td rowspan="1" colspan="1" align="center">3 (5.8%)</td></tr><tr><td rowspan="1" colspan="1" align="right">2 SNPs</td><td rowspan="1" colspan="1" align="center">4 (14.8%)</td><td rowspan="1" colspan="1" align="center">0</td></tr><tr><td rowspan="1" colspan="1" align="right">3 SNPs</td><td rowspan="1" colspan="1" align="center">1 (3.7%)</td><td rowspan="1" colspan="1" align="center">0</td></tr><tr><td rowspan="1" colspan="1" align="right">4 SNPs</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0</td></tr><tr><td colspan="3" rowspan="1" valign="bottom" align="center"><hr></td></tr><tr><td rowspan="1" colspan="1" align="right">Heterozygous for high-risk allele:</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="right">1 SNP</td><td rowspan="1" colspan="1" align="center">9 (33.3%)</td><td rowspan="1" colspan="1" align="center">22 (42.3%)</td></tr><tr><td rowspan="1" colspan="1" align="right">2 SNPs</td><td rowspan="1" colspan="1" align="center">10 (37.0%)</td><td rowspan="1" colspan="1" align="center">7 (13.5%)</td></tr><tr><td rowspan="1" colspan="1" align="right">3 SNPs</td><td rowspan="1" colspan="1" align="center">6 (22.2%)</td><td rowspan="1" colspan="1" align="center">0</td></tr><tr><td rowspan="1" colspan="1" align="right">4 SNPs</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0</td></tr><tr><td colspan="3" rowspan="1" valign="bottom" align="center"><hr></td></tr><tr><td rowspan="1" colspan="1" align="right">Homozygous or Heterozygous for high-risk allele:</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="right">1 SNP</td><td rowspan="1" colspan="1" align="center">2 (7.4%)</td><td rowspan="1" colspan="1" align="center">23 (44.2%)</td></tr><tr><td rowspan="1" colspan="1" align="right">2 SNPs</td><td rowspan="1" colspan="1" align="center">9 (33.3%)</td><td rowspan="1" colspan="1" align="center">8 (15.4%)</td></tr><tr><td rowspan="1" colspan="1" align="right">3 SNPs</td><td rowspan="1" colspan="1" align="center">12 (44.4%)</td><td rowspan="1" colspan="1" align="center">0</td></tr><tr><td rowspan="1" colspan="1" align="right">4 SNPs</td><td rowspan="1" colspan="1" align="center">4 (14.8%)</td><td rowspan="1" colspan="1" align="center">0</td></tr></tbody></table></div><div id="largeobj_idm140624685496672" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2991431/table/T5/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN7"><sup>*</sup>One case and two controls are missing data for rs10194115; three controls are missing data for rs2806864, three controls are missing data for rs10861905. Missing genotypes were conservatively counted as being homozygous for the low-risk (common) allele.</div></div></div><p id="P23" class="p p-last">Receiver-operating characteristic (ROC) curves comparing the clinical and the genetic models show that the genetic model is more accurate in classifying patients according to development of post-radiotherapy ED among this cohort of prostate cancer patients (AUC for clinical model = 0.749, AUC for genetic model = 0.983; <a href="/pmc/articles/PMC2991431/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC2991431/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140624699612544" class="figure"><a href="/pmc/articles/PMC2991431/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2991431_nihms225345f4.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms225345f4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2991431/bin/nihms225345f4.jpg"></a></div><div id="largeobj_idm140624699612544" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2991431/figure/F4/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC2991431/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="P34">ROC curves for the clinical model and the genetic model.</p><p id="P35">The genetic model includes rs2268363, rs10194115, rs2806864, rs10861905, and African ancestry. The clinical model includes age at diagnosis, stage, Gleason score, EBRT dose, hormone use, pre-treatment SHIM score, follow-up time, diabetes, hypertension, asthma, and smoking status.</p></div></div></div></div></div><div id="S15" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S15title">Discussion</h2><p id="P24" class="p p-first">To the best of our knowledge, this is the first study to use a genome-wide approach to identify genetic variants associated with development of long-term side effects of radiation therapy. Out of 512,497 SNPs, we have identified rs2268363, located in the FSH receptor gene, which is significantly associated with development of ED after using Bonferroni correction for multiple testing. The FSH receptor is expressed in Sertoli cells of the testis and is involved in testis development and function. Severe disruption of the FSH signaling pathway can lead to abnormal spermatogenesis, small testis size, and infertility in humans<sup><a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426073">25</a></sup><sup>–</sup><sup><a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426066">27</a></sup>. Mutations in the FSH gene in mice result in improper gonad development as well as hypothyroidism<sup><a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426058">27</a></sup>. Interestingly, three of the ED cases in this study reported hypothyroidism, whereas none of the control patients reported this co-morbidity (<a href="/pmc/articles/PMC2991431/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). Two of these men are heterozygous and one is homozygous for the associated risk allele of rs2268363.</p><p id="P25">We have identified additional SNPs, which although not significantly associated after Bonferroni correction, map to genes that have evidence of a biological role in erectile function and warrant further investigation. The second-ranked SNP, rs10194115 (p-value = 4.73×10<sup>−07</sup>) and another high-ranked SNP, rs5965182 (p-value = 6.25×10<sup>−06</sup>), reside within the TTC7A gene and near the HEPH gene respectively. The proteins encoded by TTC7A and HEPH are involved in regulating blood iron levels, and excessively high blood iron levels are clinically associated with low testosterone and gonadotrophin levels and erectile dysfunction<sup><a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426081">28</a></sup><sup>–</sup><sup><a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426053">31</a></sup>. Four other highly ranked SNPs (p-value &lt; 10<sup>−5</sup>) lie within the prostaglandin F2 receptor negative regulator gene. Prostaglandin F2 signaling is involved in vascular smooth muscle constriction and increase in blood pressure; physiological processes involved in erectile function<sup><a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426054">32</a></sup>. A limitation of our study is the small sample size, and it will be necessary to investigate these SNPs (or other SNPs within these genes) in a larger cohort of radiation therapy patients.</p><p id="P26">The SNPs identified in this study lie in or near genes that appear to be biologically involved in erectile function. This raises the issue that different types of radiotherapy side effects may have distinct genetic predictors, and it will be important to examine each phenotype separately. In contrast, previous studies using a candidate gene approach focused mainly on genes involved in DNA damage repair and cellular radiation response<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426068">6</a></sup><sup>–</sup><sup><a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426086">10</a></sup>. We did find some evidence for association between DNA damage repair genes and ED in this study. For example, two SNPs in the DNA ligase 4 gene (LIG4), rs7995376 and rs7489413, had p-values of 0.001 and 0.009 respectively. Similarly, SNPs rs6927534 and rs7771621 in the superoxide dismutase 2 gene (SOD2) had p-values of 0.007 and 0.01 respectively. These are similar findings to those previously reported by candidate gene studies<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426077">6</a></sup><sup>, </sup><sup><a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426061">10</a></sup>. However, it is difficult to compare this study directly to previous studies for several reasons. First, this study looked for SNPs among African American men whereas previous studies included largely Caucasian populations. Second, this study only looked at ED as a measure of radiation injury whereas some studies looked at urinary morbidity and proctitis as well. For example, Burri et al. found a SNP in SOD2 to be associated with proctitis but not ED<sup><a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426057">10</a></sup>. Finally, because several hundred thousand comparisons are made in a genome-wide study there is a high likelihood of detecting false positive associations, and so SNPs with p-values on the order of 0.001 to 0.01 (as seen for the DNA repair genes) are below the threshold of significance. However, the broader approach taken here was able to identify potentially important genes and pathways that would not have otherwise been investigated using a candidate gene approach.</p><p id="P27">Another key finding of this project is that 19 of the 30 SNPs with p-values &lt;10<sup>−5</sup>, including the top four SNPs (<a href="/pmc/articles/PMC2991431/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>), exhibit minor allele frequencies in the African HapMap population that are at least five-fold greater than the frequencies seen in the European HapMap population. Thus, if this study had been conducted using exclusively subjects of European ancestry, it is unlikely that the highest-ranking SNPs associated with ED in our African-American cohort would have been identified. Hence, our work addresses the existing health disparity in radiogenomics research, which has involved studies composed primarily of European-ancestry patients.</p><p id="P28" class="p p-last">The observation that the cases in our study shared more genetic variants with African ancestors compared to controls raises an interesting hypothesis that ancestry may be linked to radiation adverse response. It is well established that African ancestry is associated with increased risk of developing prostate cancer (<a href="http://seer.cancer.gov/csr/1975_2006/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://seer.cancer.gov/csr/1975_2006/</a>), and admixture mapping studies have identified 8q24 as a risk locus for prostate cancer among African Americans<sup><a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426064">33</a></sup><sup>–</sup><sup><a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_202426083">35</a></sup>. All of the patients in this study came from the same general population, and to the best of our knowledge there was no selection bias towards cases having a greater proportion of African ancestry than controls. It will be interesting to explore this observation in a larger cohort and to investigate the potential role of African ancestry in development of other prostate cancer radiotherapy side effects such as urinary morbidity and proctitis.</p></div><div id="S16" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S16title">Acknowledgments</h2><div class="sec"><p id="P30">This research was supported by grants RSGT-05-200-01-CCE from the ACS, PC074201 from the DOD and 1R01CA134444 from NIH.</p></div></div><div id="idm140624683045440" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140624683045440title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"></p><p id="P29" class="p p-first-last"><strong>Publisher's Disclaimer: </strong>This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.</p><p></p></div></div><div id="idm140624698807840" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140624698807840title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="citation">Robinson JW, Moritz S, Fung T. Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. <span><span class="ref-journal">Int J Radiat Oncol Biol Phys. </span>2002;<span class="ref-vol">54</span>:1063–1068.</span> [<a href="/pubmed/12419432" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Radiat+Oncol+Biol+Phys&amp;title=Meta-analysis+of+rates+of+erectile+function+after+treatment+of+localized+prostate+carcinoma&amp;author=JW+Robinson&amp;author=S+Moritz&amp;author=T+Fung&amp;volume=54&amp;publication_year=2002&amp;pages=1063-1068&amp;pmid=12419432&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="citation">Talcott JA, Manola J, Clark JA, et al.  Time course and predictors of symptoms after primary prostate cancer therapy. <span><span class="ref-journal">J Clin Oncol. </span>2003;<span class="ref-vol">21</span>:3979–3986.</span> [<a href="/pubmed/14581420" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Time+course+and+predictors+of+symptoms+after+primary+prostate+cancer+therapy&amp;author=JA+Talcott&amp;author=J+Manola&amp;author=JA+Clark&amp;volume=21&amp;publication_year=2003&amp;pages=3979-3986&amp;pmid=14581420&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="citation">Pinkawa M, Fischedick K, Gagel B, et al.  Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment. <span><span class="ref-journal">BMC Cancer. </span>2009;<span class="ref-vol">9</span>:296.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2739535/">PMC free article</a>]</span> [<a href="/pubmed/19703300" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Cancer&amp;title=Impact+of+age+and+comorbidities+on+health-related+quality+of+life+for+patients+with+prostate+cancer:+evaluation+before+a+curative+treatment&amp;author=M+Pinkawa&amp;author=K+Fischedick&amp;author=B+Gagel&amp;volume=9&amp;publication_year=2009&amp;pages=296&amp;pmid=19703300&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="citation">Wilt TJ, MacDonald R, Rutks I, et al.  Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. <span><span class="ref-journal">Ann Intern Med. </span>2008;<span class="ref-vol">148</span>:435–448.</span> [<a href="/pubmed/18252677" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=Systematic+review:+comparative+effectiveness+and+harms+of+treatments+for+clinically+localized+prostate+cancer&amp;author=TJ+Wilt&amp;author=R+MacDonald&amp;author=I+Rutks&amp;volume=148&amp;publication_year=2008&amp;pages=435-448&amp;pmid=18252677&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="citation">Safwat A, Bentzen SM, Turesson I, et al.  Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. <span><span class="ref-journal">Int J Radiat Oncol Biol Phys. </span>2002;<span class="ref-vol">52</span>:198–204.</span> [<a href="/pubmed/11777639" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Radiat+Oncol+Biol+Phys&amp;title=Deterministic+rather+than+stochastic+factors+explain+most+of+the+variation+in+the+expression+of+skin+telangiectasia+after+radiotherapy&amp;author=A+Safwat&amp;author=SM+Bentzen&amp;author=I+Turesson&amp;volume=52&amp;publication_year=2002&amp;pages=198-204&amp;pmid=11777639&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="citation">Damaraju S, Murray D, Dufour J, et al.  Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. <span><span class="ref-journal">Clin Cancer Res. </span>2006;<span class="ref-vol">12</span>:2545–2554.</span> [<a href="/pubmed/16638864" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Association+of+DNA+repair+and+steroid+metabolism+gene+polymorphisms+with+clinical+late+toxicity+in+patients+treated+with+conformal+radiotherapy+for+prostate+cancer&amp;author=S+Damaraju&amp;author=D+Murray&amp;author=J+Dufour&amp;volume=12&amp;publication_year=2006&amp;pages=2545-2554&amp;pmid=16638864&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="citation">Cesaretti JA, Stock RG, Atencio DP, et al.  A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy. <span><span class="ref-journal">Int J Radiat Oncol Biol Phys. </span>2007;<span class="ref-vol">68</span>:1410–1416.</span> [<a href="/pubmed/17490827" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Radiat+Oncol+Biol+Phys&amp;title=A+genetically+determined+dose-volume+histogram+predicts+for+rectal+bleeding+among+patients+treated+with+prostate+brachytherapy&amp;author=JA+Cesaretti&amp;author=RG+Stock&amp;author=DP+Atencio&amp;volume=68&amp;publication_year=2007&amp;pages=1410-1416&amp;pmid=17490827&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="citation">Cesaretti JA, Stock RG, Lehrer S, et al.  ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. <span><span class="ref-journal">Int J Radiat Oncol Biol Phys. </span>2005;<span class="ref-vol">61</span>:196–202.</span> [<a href="/pubmed/15629612" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Radiat+Oncol+Biol+Phys&amp;title=ATM+sequence+variants+are+predictive+of+adverse+radiotherapy+response+among+patients+treated+for+prostate+cancer&amp;author=JA+Cesaretti&amp;author=RG+Stock&amp;author=S+Lehrer&amp;volume=61&amp;publication_year=2005&amp;pages=196-202&amp;pmid=15629612&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="citation">Peters CA, Stock RG, Cesaretti JA, et al.  TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. <span><span class="ref-journal">Int J Radiat Oncol Biol Phys. </span>2008;<span class="ref-vol">70</span>:752–759.</span> [<a href="/pubmed/17689884" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Radiat+Oncol+Biol+Phys&amp;title=TGFB1+single+nucleotide+polymorphisms+are+associated+with+adverse+quality+of+life+in+prostate+cancer+patients+treated+with+radiotherapy&amp;author=CA+Peters&amp;author=RG+Stock&amp;author=JA+Cesaretti&amp;volume=70&amp;publication_year=2008&amp;pages=752-759&amp;pmid=17689884&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="citation">Burri RJ, Stock RG, Cesaretti JA, et al.  Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. <span><span class="ref-journal">Radiat Res. </span>2008;<span class="ref-vol">170</span>:49–59.</span> [<a href="/pubmed/18582155" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Radiat+Res&amp;title=Association+of+single+nucleotide+polymorphisms+in+SOD2,+XRCC1+and+XRCC3+with+susceptibility+for+the+development+of+adverse+effects+resulting+from+radiotherapy+for+prostate+cancer&amp;author=RJ+Burri&amp;author=RG+Stock&amp;author=JA+Cesaretti&amp;volume=170&amp;publication_year=2008&amp;pages=49-59&amp;pmid=18582155&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="citation">Iannuzzi CM, Atencio DP, Green S, et al.  ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. <span><span class="ref-journal">Int J Radiat Oncol Biol Phys. </span>2002;<span class="ref-vol">52</span>:606–613.</span> [<a href="/pubmed/11849780" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Radiat+Oncol+Biol+Phys&amp;title=ATM+mutations+in+female+breast+cancer+patients+predict+for+an+increase+in+radiation-induced+late+effects&amp;author=CM+Iannuzzi&amp;author=DP+Atencio&amp;author=S+Green&amp;volume=52&amp;publication_year=2002&amp;pages=606-613&amp;pmid=11849780&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="citation">Ho AY, Fan G, Atencio DP, et al.  Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy. <span><span class="ref-journal">Int J Radiat Oncol Biol Phys. </span>2007;<span class="ref-vol">69</span>:677–684.</span> [<a href="/pubmed/17517479" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Radiat+Oncol+Biol+Phys&amp;title=Possession+of+ATM+sequence+variants+as+predictor+for+late+normal+tissue+responses+in+breast+cancer+patients+treated+with+radiotherapy&amp;author=AY+Ho&amp;author=G+Fan&amp;author=DP+Atencio&amp;volume=69&amp;publication_year=2007&amp;pages=677-684&amp;pmid=17517479&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="citation">Giotopoulos G, Symonds RP, Foweraker K, et al.  The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. <span><span class="ref-journal">Br J Cancer. </span>2007;<span class="ref-vol">96</span>:1001–1007.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2360097/">PMC free article</a>]</span> [<a href="/pubmed/17325707" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Cancer&amp;title=The+late+radiotherapy+normal+tissue+injury+phenotypes+of+telangiectasia,+fibrosis+and+atrophy+in+breast+cancer+patients+have+distinct+genotype-dependent+causes&amp;author=G+Giotopoulos&amp;author=RP+Symonds&amp;author=K+Foweraker&amp;volume=96&amp;publication_year=2007&amp;pages=1001-1007&amp;pmid=17325707&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="citation">Andreassen CN, Overgaard J, Alsner J, et al.  ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. <span><span class="ref-journal">Int J Radiat Oncol Biol Phys. </span>2006;<span class="ref-vol">64</span>:776–783.</span> [<a href="/pubmed/16338099" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Radiat+Oncol+Biol+Phys&amp;title=ATM+sequence+variants+and+risk+of+radiation-induced+subcutaneous+fibrosis+after+postmastectomy+radiotherapy&amp;author=CN+Andreassen&amp;author=J+Overgaard&amp;author=J+Alsner&amp;volume=64&amp;publication_year=2006&amp;pages=776-783&amp;pmid=16338099&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="citation">Andreassen CN, Alsner J. Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. <span><span class="ref-journal">Radiother Oncol. </span>2009;<span class="ref-vol">92</span>:299–309.</span> [<a href="/pubmed/19683821" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Radiother+Oncol&amp;title=Genetic+variants+and+normal+tissue+toxicity+after+radiotherapy:+a+systematic+review&amp;author=CN+Andreassen&amp;author=J+Alsner&amp;volume=92&amp;publication_year=2009&amp;pages=299-309&amp;pmid=19683821&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="citation">Barnett GC, West CM, Dunning AM, et al.  Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. <span><span class="ref-journal">Nat Rev Cancer. </span>2009;<span class="ref-vol">9</span>:134–142.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2670578/">PMC free article</a>]</span> [<a href="/pubmed/19148183" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=Normal+tissue+reactions+to+radiotherapy:+towards+tailoring+treatment+dose+by+genotype&amp;author=GC+Barnett&amp;author=CM+West&amp;author=AM+Dunning&amp;volume=9&amp;publication_year=2009&amp;pages=134-142&amp;pmid=19148183&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="citation">Rosen RC, Cappelleri JC, Smith MD, et al.  Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. <span><span class="ref-journal">Int J Impot Res. </span>1999;<span class="ref-vol">11</span>:319–326.</span> [<a href="/pubmed/10637462" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Impot+Res&amp;title=Development+and+evaluation+of+an+abridged,+5-item+version+of+the+International+Index+of+Erectile+Function+(IIEF-5)+as+a+diagnostic+tool+for+erectile+dysfunction&amp;author=RC+Rosen&amp;author=JC+Cappelleri&amp;author=MD+Smith&amp;volume=11&amp;publication_year=1999&amp;pages=319-326&amp;pmid=10637462&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="citation">Atencio DP, Iannuzzi CM, Green S, et al.  Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high-performance liquid chromatography. <span><span class="ref-journal">Environ Mol Mutagen. </span>2001;<span class="ref-vol">38</span>:200–208.</span> [<a href="/pubmed/11746755" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Environ+Mol+Mutagen&amp;title=Screening+breast+cancer+patients+for+ATM+mutations+and+polymorphisms+by+using+denaturing+high-performance+liquid+chromatography&amp;author=DP+Atencio&amp;author=CM+Iannuzzi&amp;author=S+Green&amp;volume=38&amp;publication_year=2001&amp;pages=200-208&amp;pmid=11746755&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="citation">Korn JM, Kuruvilla FG, McCarroll SA, et al.  Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:1253–1260.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2756534/">PMC free article</a>]</span> [<a href="/pubmed/18776909" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Integrated+genotype+calling+and+association+analysis+of+SNPs,+common+copy+number+polymorphisms+and+rare+CNVs&amp;author=JM+Korn&amp;author=FG+Kuruvilla&amp;author=SA+McCarroll&amp;volume=40&amp;publication_year=2008&amp;pages=1253-1260&amp;pmid=18776909&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="citation">Purcell S, Neale B, Todd-Brown K, et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>:559–575.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=PLINK:+a+tool+set+for+whole-genome+association+and+population-based+linkage+analyses&amp;author=S+Purcell&amp;author=B+Neale&amp;author=K+Todd-Brown&amp;volume=81&amp;publication_year=2007&amp;pages=559-575&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="citation">Team RDC. <span class="ref-journal">R: A language and environment for statistical computing.</span> Vienna, Austria: R Foundation for Statistical Computing; 2009.  2.10.0 ed. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=R:+A+language+and+environment+for+statistical+computing&amp;publication_year=2009&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="citation">The International HapMap Project. <span><span class="ref-journal">Nature. </span>2003;<span class="ref-vol">426</span>:789–796.</span> [<a href="/pubmed/14685227" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The+International+HapMap+Project&amp;volume=426&amp;publication_year=2003&amp;pages=789-796&amp;pmid=14685227&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="citation">Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. <span><span class="ref-journal">Genetics. </span>2000;<span class="ref-vol">155</span>:945–959.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1461096/">PMC free article</a>]</span> [<a href="/pubmed/10835412" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genetics&amp;title=Inference+of+population+structure+using+multilocus+genotype+data&amp;author=JK+Pritchard&amp;author=M+Stephens&amp;author=P+Donnelly&amp;volume=155&amp;publication_year=2000&amp;pages=945-959&amp;pmid=10835412&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="citation">Montana G, Pritchard JK. Statistical tests for admixture mapping with case-control and cases-only data. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">75</span>:771–789.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1182107/">PMC free article</a>]</span> [<a href="/pubmed/15386213" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Statistical+tests+for+admixture+mapping+with+case-control+and+cases-only+data&amp;author=G+Montana&amp;author=JK+Pritchard&amp;volume=75&amp;publication_year=2004&amp;pages=771-789&amp;pmid=15386213&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="citation">Simoni M, Weinbauer GF, Gromoll J, et al.  Role of FSH in male gonadal function. <span><span class="ref-journal">Ann Endocrinol (Paris) </span>1999;<span class="ref-vol">60</span>:102–106.</span> [<a href="/pubmed/10456180" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Endocrinol+(Paris)&amp;title=Role+of+FSH+in+male+gonadal+function&amp;author=M+Simoni&amp;author=GF+Weinbauer&amp;author=J+Gromoll&amp;volume=60&amp;publication_year=1999&amp;pages=102-106&amp;pmid=10456180&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="citation">Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. <span><span class="ref-journal">Endocr Rev. </span>1997;<span class="ref-vol">18</span>:739–773.</span> [<a href="/pubmed/9408742" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;title=The+follicle-stimulating+hormone+receptor:+biochemistry,+molecular+biology,+physiology,+and+pathophysiology&amp;author=M+Simoni&amp;author=J+Gromoll&amp;author=E+Nieschlag&amp;volume=18&amp;publication_year=1997&amp;pages=739-773&amp;pmid=9408742&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="citation">Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. <span><span class="ref-journal">Endocr Rev. </span>2000;<span class="ref-vol">21</span>:551–583.</span> [<a href="/pubmed/11041448" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;title=Mutations+of+gonadotropins+and+gonadotropin+receptors:+elucidating+the+physiology+and+pathophysiology+of+pituitary-gonadal+function&amp;author=APN+Themmen&amp;author=IT+Huhtaniemi&amp;volume=21&amp;publication_year=2000&amp;pages=551-583&amp;pmid=11041448&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="citation">Altes A, Ruiz A, Martinez C, et al.  The relationship between iron overload and clinical characteristics in a Spanish cohort of 100 C282Y homozygous hemochromatosis patients. <span><span class="ref-journal">Ann Hematol. </span>2007;<span class="ref-vol">86</span>:831–835.</span> [<a href="/pubmed/17639389" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Hematol&amp;title=The+relationship+between+iron+overload+and+clinical+characteristics+in+a+Spanish+cohort+of+100+C282Y+homozygous+hemochromatosis+patients&amp;author=A+Altes&amp;author=A+Ruiz&amp;author=C+Martinez&amp;volume=86&amp;publication_year=2007&amp;pages=831-835&amp;pmid=17639389&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="citation">Kelly TM, Edwards CQ, Meikle AW, et al.  Hypogonadism in hemochromatosis: reversal with iron depletion. <span><span class="ref-journal">Ann Intern Med. </span>1984;<span class="ref-vol">101</span>:629–632.</span> [<a href="/pubmed/6435491" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=Hypogonadism+in+hemochromatosis:+reversal+with+iron+depletion&amp;author=TM+Kelly&amp;author=CQ+Edwards&amp;author=AW+Meikle&amp;volume=101&amp;publication_year=1984&amp;pages=629-632&amp;pmid=6435491&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="citation">Vulpe CD, Kuo YM, Murphy TL, et al.  Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. <span><span class="ref-journal">Nat Genet. </span>1999;<span class="ref-vol">21</span>:195–199.</span> [<a href="/pubmed/9988272" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Hephaestin,+a+ceruloplasmin+homologue+implicated+in+intestinal+iron+transport,+is+defective+in+the+sla+mouse&amp;author=CD+Vulpe&amp;author=YM+Kuo&amp;author=TL+Murphy&amp;volume=21&amp;publication_year=1999&amp;pages=195-199&amp;pmid=9988272&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="citation">White RA, McNulty SG, Nsumu NN, et al.  Positional cloning of the Ttc7 gene required for normal iron homeostasis and mutated in hea and fsn anemia mice. <span><span class="ref-journal">Genomics. </span>2005;<span class="ref-vol">85</span>:330–337.</span> [<a href="/pubmed/15718100" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genomics&amp;title=Positional+cloning+of+the+Ttc7+gene+required+for+normal+iron+homeostasis+and+mutated+in+hea+and+fsn+anemia+mice&amp;author=RA+White&amp;author=SG+McNulty&amp;author=NN+Nsumu&amp;volume=85&amp;publication_year=2005&amp;pages=330-337&amp;pmid=15718100&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="citation">Negishi M, Sugimoto Y, Ichikawa A. Prostanoid receptors and their biological actions. <span><span class="ref-journal">Prog Lipid Res. </span>1993;<span class="ref-vol">32</span>:417–434.</span> [<a href="/pubmed/8309950" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prog+Lipid+Res&amp;title=Prostanoid+receptors+and+their+biological+actions&amp;author=M+Negishi&amp;author=Y+Sugimoto&amp;author=A+Ichikawa&amp;volume=32&amp;publication_year=1993&amp;pages=417-434&amp;pmid=8309950&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="citation">Robbins C, Torres JB, Hooker S, et al.  Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. <span><span class="ref-journal">Genome Res. </span>2007;<span class="ref-vol">17</span>:1717–1722.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2099580/">PMC free article</a>]</span> [<a href="/pubmed/17978284" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Res&amp;title=Confirmation+study+of+prostate+cancer+risk+variants+at+8q24+in+African+Americans+identifies+a+novel+risk+locus&amp;author=C+Robbins&amp;author=JB+Torres&amp;author=S+Hooker&amp;volume=17&amp;publication_year=2007&amp;pages=1717-1722&amp;pmid=17978284&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="citation">Freedman ML, Haiman CA, Patterson N, et al.  Admixture mapping identifies 8q24 as a prostate cancer risk locus in Afrirican-American men. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2006;<span class="ref-vol">103</span>:14068–14073.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1599913/">PMC free article</a>]</span> [<a href="/pubmed/16945910" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Admixture+mapping+identifies+8q24+as+a+prostate+cancer+risk+locus+in+Afrirican-American+men&amp;author=ML+Freedman&amp;author=CA+Haiman&amp;author=N+Patterson&amp;volume=103&amp;publication_year=2006&amp;pages=14068-14073&amp;pmid=16945910&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="citation">Bock CH, Schwartz AG, Ruterbusch JJ, et al.  Results from a prostate cancer admixture mapping study in African-American men. <span><span class="ref-journal">Hum Genet. </span>2009;<span class="ref-vol">126</span>:637–642.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2975267/">PMC free article</a>]</span> [<a href="/pubmed/19568772" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Genet&amp;title=Results+from+a+prostate+cancer+admixture+mapping+study+in+African-American+men&amp;author=CH+Bock&amp;author=AG+Schwartz&amp;author=JJ+Ruterbusch&amp;volume=126&amp;publication_year=2009&amp;pages=637-642&amp;pmid=19568772&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2991431&amp;issue-id=192004&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#idm140624697105344title">Abstract</a></li><li><a href="#S5title">Introduction</a></li><li><a href="#S6title">Methods and Materials</a></li><li><a href="#S10title">Results</a></li><li><a href="#S15title">Discussion</a></li><li><a href="#S16title">Acknowledgments</a></li><li><a href="#idm140624683045440title">Footnotes</a></li><li><a href="#idm140624698807840title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2991431/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2991431/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2991431/pdf/nihms225345.pdf">PDF (966K)</a></li> | <li><a href="#" data-citationid="PMC2991431" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2991431%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2991431%2F&amp;text=Genome%20Wide%20Association%20Study%20to%20Identify%20Single%20Nucleotide%20Polymorphisms%20(SNPs)%20Associated%20with%20the%20Development%20of%20Erectile%20Dysfunction%20in%20African-American%20Men%20Following%20Radiotherapy%20for%20Prostate%20Cancer" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2991431%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="20932654" data-aiid="2991431" data-aid="2991431" data-iid="192004" data-domainid="319" data-domain="nihpa" data-accid="PMC2991431" data-md5="c050eb765c9734a7d84d4ace0b7bf331"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T06:03:50-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal104&amp;ncbi_phid=CE8B2595DD5105E1000000000846056D&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2991431%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2991431/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>